TMPA significantly ameliorated lipid accumulation in HepG2 cells exposed to FFAs compared with DMSO + FFAs, as assessed by Oil red O staining. In primary hepatocytes exposed to FFAs, TMPA reduced lipid accumulation and fat vacuoles compared with DMSO + FFAs, as assessed by Oil red O stain quantification. [1]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Reduced Lipid Accumulation in HepG2 Cells
Cell-based study · HepG2 cells [1]
In HepG2 cells exposed to FFAs, TMPA significantly ameliorated lipid accumulation compared with DMSO + FFAs, as assessed by Oil red O staining.
Literature-Reported Treatment Conditions
- Treatment concentration
- 10µm
- Exposure duration
- incubated for 6h before exposure to FFAs for 24h
- Method
- added the solution to HepG2 cells and primary hepatocytes
- Vehicle
- dimethyl sulfoxide
- Co-treatment
- Other interventions in this design: FFAs mixture (OA:PA = 2:1) 0.25mM. Compound effect isolated by the comparison: DMSO + FFAs.
Methods and source locations
Compound reported in the paper: TMPA
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Methods > Reagents (S7); Methods > Induction of Fat-Overload in HepG2 Cells and Primary Hepatocytes (S16); Methods > Hematoxylin-Eosin Staining and Oil Red O Staining (S25, S26); Results > TMPA Reduced Lipid Accumulation Following FFAs Stimulation in HepG2 Cells and Primary Hepatocytes (S81); Figure 3 legend (S120, S122, S123, S124, S125)
Oil red O staining: Oil red O staining; comparator: DMSO + FFAs — Results > TMPA Reduced Lipid Accumulation Following FFAs Stimulation in HepG2 Cells and Primary Hepatocytes (S81); Figure 3 legend (S120, S123, S125)
Reduced Lipid Accumulation and Fat Vacuoles in Primary Hepatocytes
Cell-based study · primary hepatocytes [1]
In primary hepatocytes exposed to FFAs, TMPA reduced lipid accumulation and fat vacuoles compared with DMSO + FFAs, as assessed by Oil red O stain quantification.
Literature-Reported Treatment Conditions
- Treatment concentration
- 10µm
- Exposure duration
- incubated for 6h before exposure to FFAs for 24h
- Method
- added the solution to HepG2 cells and primary hepatocytes
- Vehicle
- dimethyl sulfoxide
- Co-treatment
- Other interventions in this design: FFAs mixture (OA:PA = 2:1) 0.25mM. Compound effect isolated by the comparison: DMSO + FFAs.
Methods and source locations
Compound reported in the paper: TMPA
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Methods > Reagents (S7); Methods > Induction of Fat-Overload in HepG2 Cells and Primary Hepatocytes (S16); Methods > Hematoxylin-Eosin Staining and Oil Red O Staining (S25, S26); Results > TMPA Reduced Lipid Accumulation Following FFAs Stimulation in HepG2 Cells and Primary Hepatocytes (S81, S82); Figure 3 legend (S123, S124, S126, S127)
Oil red O stain quantification: Oil red O stain quantification; comparator: DMSO + FFAs — Results > TMPA Reduced Lipid Accumulation Following FFAs Stimulation in HepG2 Cells and Primary Hepatocytes (S81, S82); Figure 3 legend (S123, S126, S127)